Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
70
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

Lorie A Ellis1 Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA
,
Elisabetta Malangone-Monaco2 Life Sciences, IBM Watson Health, Armonk, NY, USA, [email protected]Correspondence[email protected]
,
Helen Varker3 Life Sciences, IBM Watson Health, Cambridge, MA, USA
,
Diana Stetsovsky3 Life Sciences, IBM Watson Health, Cambridge, MA, USA
,
Maureen Kubacki1 Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA
,
Raphael J DeHoratius1 Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA;4 Janssen Immunology, Medical Affairs, Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia, PA, USA
&
Shelly Kafka1 Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA
 show all
Pages 99-110 | Published online: 15 Jan 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.